Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer.
Ji X, Fu T, Bu ZD, Zhang J, Wu XJ, Zong XL, Jia ZY, Fan B, Zhang YN, Ji JF.
BMC Cancer. 2016 Oct 3;16(1):765. doi: 10.1186/s12885-016-2814-z.
PMID:27716191
Clinical Relevance of Splenic Hilar Lymph Node Dissection for Proximal Gastric Cancer: A Propensity Score-Matching Case-Control Study.
Lin JX, Wang ZK, Huang YQ, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Zheng CH, Huang CM, Li P.
Ann Surg Oncol. 2021 Oct;28(11):6649-6662. doi: 10.1245/s10434-021-09830-1. Epub 2021 Mar 25.
PMID:33768400
Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.
Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
Shin SH, Jung H, Choi SH, An JY, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S.
Ann Surg Oncol. 2009 May;16(5):1304-9. doi: 10.1245/s10434-009-0389-5. Epub 2009 Feb 25.
PMID:19241107
Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types.
Kano Y, Ohashi M, Ida S, Kumagai K, Makuuchi R, Sano T, Hiki N, Nunobe S.